You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
立方製藥(003020.SZ):擬與立方投資簽署《代爲培育協議》
格隆匯 03-10 19:08

格隆匯3月10日丨立方製藥(003020.SZ)公佈,由於藥品研發的投資大、週期長、環節多,且易受到不可控因素影響,研發進度及結果、未來產品市場競爭形勢均存在不確定性,爲降低公司投資風險,有效獲取商業機會,同時避免公司控股股東與公司構成同業競爭,最大限度保護公司及全體股東特別是中小股東利益,公司擬與立方投資簽署《代爲培育協議》,委託立方投資按照市場原則爲公司代爲培育創新藥研究相關項目。

代培育項目擬以南京米諾維醫藥有限公司(簡稱“米諾維”“培育標的”或“標的公司”)作爲實施主體,立方投資擬以現金增資方式取得培育標的20%的股權。培育標的開展精神疾病領域的藥品研發、生產和銷售,藥品滿足上市條件後,公司擁有藥品在中華人民共和國大陸地區同等條件下的優先代工權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account